Temporary loss of smell emerged as a common indicator of COVID-19 early in the pandemic. Research into the cause and treatment of the condition, known as anosmia, is ongoing, though recent studies have brought us one step closer to answers.
Category: Patient Safety & Outcomes
What an increasingly anxious workforce means for patient care
Whether a school in Uvalde, Texas, or a hospital campus in Tulsa, Okla., a recent series of violent events are constant reminders of the potential for what could unfold on healthcare workers’ home campuses. The omnipresent anxiety over gun violence in …
Police kill armed patient at Baylor Scott & White hospital
Police fatally shot a patient in the emergency wing of Baylor Scott & White Medical Center–Irving on June 29 after he opened fire on officers, according to local news reports.
Long COVID-19 hard to recognize in older adults
Long COVID-19 is often overlooked in older people despite the age group being at a higher risk to develop symptoms, The Washington Post reported June 26.
1 patient dead in stabbing at Las Vegas hospital
A patient at University Medical Center in Las Vegas stabbed two other patients July 23, killing one, according to police.
WHO updates respiratory support guidelines for COVID-19 patients
The World Health Organization issued a fourth update to its living guidelines on COVID-19 clinical management to include suggesting the use of three devices over standard oxygen therapy, according to a press release sent to Becker’s. The suggestion is …
Long COVID-19 in kids: 3 things to know
While many studies have estimated how prevalent long COVID-19 is in adults, fewer have explored the risk among children.
Joint Commission warns of ‘diagnostic overshadowing’ in new sentinel event alert
The Joint Commission on June 22 issued a sentinel event alert to turn more attention to the effects of diagnostic overshadowing — the attribution of symptoms to an existing diagnosis instead of a possible comorbid condition — and actions to address it….
Insufficient drug exposure likely behind COVID-19 rebound symptoms after Paxlovid: Study
Drug resistance or impaired immunity against the coronavirus are likely not the cause of rebound symptoms some patients experience after taking Pfizer’s antiviral Paxlovid, according to a new study from University of California San Diego researchers.&n…
Women more likely to experience long COVID-19, study finds
Four weeks after testing positive for COVID-19 and feeling symptoms, women encountered recurring symptoms more often than men, according to a study published June 21 in Current Medical Research and Opinion.
